RN7SL73P

Across TCGA pan-cancer cohorts, RN7SL73P RNA is linked to patient survival in 17 of 34 cancer types, making it the most broadly survival-associated RN7SL73P data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RN7SL73P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL73P expression acts as an unfavorable survival marker, although some lineages such as PAAD and COAD show a favorable association.

PAAD, MESO, and BLCA are the cancer types where RN7SL73P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	OS	Tertile	All	0.680	0.249	.002	60	view →
MESO	OS	Tertile	All	0.052	0.528	.016	54	view →
BLCA	OS	Tertile	All	0.438	0.638	.031	27	view →
DLBC	OS	Tertile	II,III,IV	0.586	0.949	.014	27	view →
KICH	DFS	Quartile	All	0.422	0.944	.001	26	view →
THYM	OS	Tertile	III,IV	0.212	1.000	.014	18	view →
KIRC	DFS	Tertile	IV	0.217	0.603	.013	18	view →
KIRP	DFS	Quartile	IV	0.370	0.712	.010	13	view →
THCA	OS	Tertile	III,IV	0.919	0.986	.028	12	view →
COAD	DFS	Tertile	III,IV	0.859	0.604	.026	9	view →
SKCM	OS	Tertile	IV	0.415	0.861	.014	9	view →
CHOL	OS	Tertile	All	0.114	0.623	.033	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 17 lineages.

RN7SL73P–PAAD (OS)

Open the PAAD breakdown →